Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine

AIDS Research and Human Retroviruses

Volumn 22, Issue 7, 2006, Pages 667-677

  Blazevic, Vesna ^a   Männik, Andres ^b   Malm, Maria ^a   Sikut, Rein ^b   Valtavaara, Minna ^a   Toots, Urve ^b   Ustav, Mart ^b   Krohn, Kai ^a  

^a FIT Biotech Oyj Plc   (Finland)

^b FIT Biotech Oyj Plc Eesti   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAG PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; PLASMID DNA; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA VECTOR; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FUSION GENE; GENE CONSTRUCT; GENE GUN; GENE INDUCTION; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE THERAPY; VIRUS IMMUNITY;

AIDS VACCINES; ANIMALS; ANTIBODIES, ANTINUCLEAR; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; FEMALE; GENE PRODUCTS, GAG; GENE PRODUCTS, NEF; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; HIV-1; HUMANS; INJECTIONS, INTRAMUSCULAR; JURKAT CELLS; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTES; VACCINES, DNA; VIRAL PROTEINS;

EID: 33745944382     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.667     Document Type: Article

References (38)

1. Brenner B, Wainberg MA, Salomon H, et al.: Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Int J Antimicrob Agents 2000;16:429-434.
2. Martinez-Picado J, DePasquale MP, Kartsonis N, et al.: Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci USA 2000;97:10948-10953.
3. Letvin N: Strategies for an HIV vaccine. J Clin Invest 2002; 109:15-20.
4. Greenough TC, Brettler DB, Somasundaran M, Panicali DL, and Sullivan JL: Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo. J Infect Dis 1997;176:118-125.
5. Betts MR, Krowka JF, Kepler TB, et al.: Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses 1999;15:1219-1228.
6. Rowland-Jones S, Sutton J, Ariyoshi K, et al.: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59-64.
7. Matano T, Shibata R, Siemon C, Connors M, Lane HC, and Martin MA: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998;72:164-169.
8. Ensoli B and Cafaro A: Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus. AIDS Clin Rev 2000;1:23-61.
9. Addo MM, Altfeld M, Rosenberg ES, et al.: The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc Natl Acad Sci USA 2001;98:1781-1786.
10. Gotch F: Cross-clade T cell recognition of HIV-1. Curr Opin Immunol 1998;10:388-392.
11. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, and Desrosiers RC: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996;70:3724-3733.
12. Barouch DH, Santra S, Schmitz JE, et al.: Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000;290:486-492.
13. Ayyavoo V, Kudchodkar S, Ramanathan MP, et al.: Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes. AIDS 2000;14:1-9.
14. Calarota S, Bratt G, Nordlund S, et al.: Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 1998;351:1320-1325.
15. Barouch DH, Kunstman J, Kuroda MJ, et al.: Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002;415:335-339.
16. Hinkula J, Svanholm C, Schwartz S, et al.: Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes. J Virol. 1997;71: 5528-5539.
17. Krohn K, Stanescu I, Blazevic V, Vesikari T, Ranki A, and Ustav M: A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A, B and C subtypes and the ancestor sequence of the F, G and H subtypes. Preclinical and clinical studies. Microbes Infect 2005;7: 1405-1413.
18. Hanke T and McMichael A: Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS. Immunol Lett 1999;66:177-181.
19. Takahashi H, Cohen J, Hosmalin A, et al.: An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1988;85:3105-3109.
20. Yanisch-Perron C, Vieira J, and Messing J: Improved M13 phage cloning vectors and host strains: Nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985;33:103-119.
21. Korber B, Brander C, Haynes B, Koup R, Kuiken C, Moore JP, Walker BD, and Watkins DI (eds.): HIV Molecular Immunology 2000. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM.
22. Ustav M and Stenlund A: Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J 1991;10:449-457.
23. Qiu JT, Song R, Dettenhofer M, et al.: Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J Virol 1999;73:9145-9152.
24. Singer DS, Kohn LD, Zinger H, and Mozes E: Methimazole prevents induction of experimental systemic lupus erythematosus in mice. J Immunol 1994;153:873-880.
25. Collings A, Pitkänen J, Strengell M, et al.: Humoral and cellular immune responses to HIV-1 nef in mice DNA-immunised with non-replicating or self-replicating expression vectors. Vaccine 1999;18:460-467.
26. Tobery TW and Siliciano RF: Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J Exp Med 1997;185:909-920.
27. + memory T cells. J Exp Med 1997;186:859-865.
28. Caputo A, Gavioli R, Altavilla G, et al.: Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat. Vaccine 2003;21: 1103-1111.
29. Tuomela M, Malm M, Wallen M, Stanescu I, Krohn K, and Peterson P: Biodistribution and general safety of a naked DNA plasmid, GTU-MultiHIV, in a rat, using a quantitative PCR method. Vaccine 2005;23:890-896.
30. Cohen AD, Boyer JD, and Weiner DB: Modulating the immune response to genetic immunization. FASEB J 1998;12:1611-1626.
31. Wolff JA: Naked DNA transport and expression in mammalian cells. Neuromuscul Disord 1997;7:314-318.
32. Pertmer TM, Eisenbraun MD, McCabe D, Prayaga SK, Fuller DH, and Haynes JR: Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 1995;13:1427-1430.
33. Creusot RJ, Thomsen LL, van Wely CA, Topley P, Tite JP, and Chain BM: Early commitment of adoptively transferred CD4+ T cells following particle-mediated DNA vaccination: implications for the study of immunomodulation. Vaccine 2001;19:1678-1687.
34. + T lymphocyte responses. Eur J Immunol 2004;34:1011-1020.
35. Blazevic V, Pinto LA, Trubey CM, and Shearer GM: Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2- dependent mechanism. J Leukoc Biol 2000;67: 817-824.
36. Tähtinen M, Strengell M, Collings A, et al.: DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector. Vaccine 2001;19:2039-2047.
37. Kjerrström A, Hinkula J, Engstrom G, et al.: Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines. Virology 2001;284:46-61.
38. Kong WP, Huang Y, Yang ZY, Chakrabarti BK, Moodie Z, and Nabel G: Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines. J Virol 2003;77:12764-12772.